Although easier than predicting the weather, technology assessment is a challenging task. A combination of scientific, patent, legal/regulatory, manufacturing, commercial and competitive aspects have to be taken into account when an invention or project is assessed.

Wiborg supports technology transfer offices, potential licensees and investors in identifying and assessing inventions and projects within life science. Since 2002, the team at Wiborg has assessed close to 300 projects in the areas of:

• Antibodies
• New drugs and drug targets
• Cancer biomarkers
• Cardiovascular implants
• Drug screening technologies
• Medical devices
• Second medical indication of a drug
• Transgenic plants

In our assessment, we often take advantage of specialists around the world. We have a large proprietary database of more than 200 specialists and medical experts within many therapeutic areas with whom we have established good relations. Additionally, we use a network of consultants in Europe, USA and Asia.